Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...

This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that ...

Opdivo’s sales rose 9% to $4.82 billion in the first half of 2025. PFE’s Price Performance, Valuation and Estimates Pfizer’s ...

By stepping out as the first biopharma to win a three-year exemption from President Donald Trump’s earlier-announced plans for 100% tariffs, in return for agreeing to manufacture more of its drugs in ...

Pfizer's 7%+ yield signals low market expectations amid pipeline setbacks and looming patent cliffs, but the dividend remains well-covered for now. Cost discipline is driving margin improvement, with ...

According to a Securities and Exchange Commission (SEC) filing dated October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV ...

Shares of global pharmaceutical company Pfizer (NYSE:PFE) jumped 5.9% in the afternoon session after the company reached an agreement with the U.S. government to lower drug prices and reported ...

Pfizer Inc. Chief Executive Albert Bourla said the company secured a three-year grace period from President Trump’s promised tariffs on pharmaceuticals in a deal that would lower some of the company’s ...